Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection (2020)

First Author: Zuo J

Attributed to: A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-101480/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-101480/v1

Type: Preprint